
Cidazo 250mg/31.25mg Injection
Marketer
Delwis Healthcare Pvt Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Cidazo 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action medication, combats various bacterial infections. Its mechanism inhibits microbial growth, curbing infection spread. Administration must be solely under a physician's guidance; strict adherence to the prescribed schedule is vital. Complete the full course, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects require immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand urgent medical care. Inform your doctor of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, avoid driving if experiencing somnolence or dizziness. Adequate rest, proper nutrition, and hydration support recovery. Your doctor may order tests to monitor treatment effectiveness.
Primary Ingredients of Cidazo 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Cidazo 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cidazo 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cidazo 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Cidazo 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cidazo 250mg/31.25mg Injection works:
Cidazo 250mg/31.25mg injection combines ceftazidime, a crucial antibiotic, with tazobactam, a beta-lactamase inhibitor. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Tazobactam counters bacterial resistance, boosting ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cidazo 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Cidazo 250mg/31.25mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; yet, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Cidazo 250mg/31.25mg Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Cidazo 250mg/31.25mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Cidazo 250mg/31.25mg Injection. Dosage modification of Cidazo 250mg/31.25mg Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
The administration of Cidazo 250mg/31.25mg Injection requires careful consideration in individuals suffering from significant hepatic impairment. Dosage modification of Cidazo 250mg/31.25mg Injection might be necessary. Medical advice should be sought.
What if you forget to take Cidazo 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Cidazo 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Cidazo 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
